tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Arrowhead files request for regulatory clearance to initiate ARO-DIMER-PA trial
The FlyArrowhead files request for regulatory clearance to initiate ARO-DIMER-PA trial
7d ago
ARWR
Arrowhead Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating
29d ago
ARWR
Arrowhead Pharmaceuticals Faces Patent Lawsuit from Ionis
PremiumCompany Announcements
Arrowhead Pharmaceuticals Faces Patent Lawsuit from Ionis
1M ago
8K
ARWR
Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute
PremiumCompany Announcements
Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute
1M ago
8K
ARWR
Arrowhead files complaint for declaratory judgment against Ionis
PremiumThe Fly
Arrowhead files complaint for declaratory judgment against Ionis
1M ago
ARWR
IONS
Arrowhead requests regulatory clearance to initiate ARO-MAPT clinical trial
PremiumThe FlyArrowhead requests regulatory clearance to initiate ARO-MAPT clinical trial
1M ago
ARWR
Sarepta price target raised to $15 from $12 at Leerink
Premium
The Fly
Sarepta price target raised to $15 from $12 at Leerink
1M ago
ARWR
SRPT
Cautious Optimism: Hold Rating for Arrowhead Pharmaceuticals Amid Novartis Collaboration and Balance Sheet Concerns
Premium
Ratings
Cautious Optimism: Hold Rating for Arrowhead Pharmaceuticals Amid Novartis Collaboration and Balance Sheet Concerns
1M ago
ARWR
Hold Rating on Arrowhead Pharmaceuticals Amid Strategic Partnership and Market Competition
PremiumRatings
Hold Rating on Arrowhead Pharmaceuticals Amid Strategic Partnership and Market Competition
1M ago
ARWR
Arrowhead Pharmaceuticals Partners with Novartis for ARO-SNCA
PremiumCompany Announcements
Arrowhead Pharmaceuticals Partners with Novartis for ARO-SNCA
1M ago
8K
ARWR
Arrowhead Pharmaceuticals: Strategic Partnerships and Promising Pipeline Drive Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Strategic Partnerships and Promising Pipeline Drive Buy Rating
1M ago
ARWR
Arrowhead, Novartis announce licensing and collaboration agreement for ARO-SNCA
PremiumThe Fly
Arrowhead, Novartis announce licensing and collaboration agreement for ARO-SNCA
1M ago
NVS
ARWR
Arrowhead 9.265M share Block Trade priced at $19.00
PremiumThe FlyArrowhead 9.265M share Block Trade priced at $19.00
2M ago
ARWR
Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
Premium
The Fly
Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
2M ago
ARWR
SRPT
Arrowhead redeems $50M of common stock
Premium
The Fly
Arrowhead redeems $50M of common stock
2M ago
ARWR
SRPT
Arrowhead Pharmaceuticals: Positioned for Growth with Pivotal siRNA Program and Expanding Pipeline
PremiumRatings
Arrowhead Pharmaceuticals: Positioned for Growth with Pivotal siRNA Program and Expanding Pipeline
2M ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights Strategic Progress
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call Highlights Strategic Progress
2M ago
ARWR
Arrowhead Pharmaceuticals: Balancing Promising Launch Preparations with Pipeline Uncertainties
PremiumRatings
Arrowhead Pharmaceuticals: Balancing Promising Launch Preparations with Pipeline Uncertainties
2M ago
ARWR
Arrowhead Pharmaceuticals Advances RNAi Therapeutics Pipeline
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances RNAi Therapeutics Pipeline
2M ago
ARWR
Arrowhead Pharmaceuticals: Buy Rating Affirmed on Promising Pipeline and Late-Stage Developments
PremiumRatingsArrowhead Pharmaceuticals: Buy Rating Affirmed on Promising Pipeline and Late-Stage Developments
2M ago
ARWR
Arrowhead reports Q3 EPS ($1.26), consensus ($1.10)
Premium
The Fly
Arrowhead reports Q3 EPS ($1.26), consensus ($1.10)
2M ago
ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 Earnings Cheat Sheet
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >